These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 30452915)

  • 1. Adenoma detection rates in colonoscopies for positive fecal immunochemical tests versus direct screening colonoscopies.
    Wong JCT; Chiu HM; Kim HS; Byeon JS; Matsuda T; Kobayashi N; Wu DC; Ong DE; Sung JJY;
    Gastrointest Endosc; 2019 Mar; 89(3):607-613.e1. PubMed ID: 30452915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining Benchmarks for Adenoma Detection Rate and Adenomas Per Colonoscopy in Patients Undergoing Colonoscopy Due to a Positive Fecal Immunochemical Test.
    Hilsden RJ; Bridges R; Dube C; McGregor SE; Naugler C; Rose SM; Rostom A; Heitman SJ
    Am J Gastroenterol; 2016 Dec; 111(12):1743-1749. PubMed ID: 27725649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenoma Detection Rate in Asymptomatic Patients with Positive Fecal Immunochemical Tests.
    Kligman E; Li W; Eckert GJ; Kahi C
    Dig Dis Sci; 2018 May; 63(5):1167-1172. PubMed ID: 29468377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of fecal immunochemical test cut-off levels on adenoma detection rate: a systematic review and meta-analysis.
    Zarandi-Nowroozi M; Taghiakbari M; Barkun A; Pohl H; Nauche B; Chagnon M; von Renteln D
    Scand J Gastroenterol; 2024 Aug; 59(8):882-892. PubMed ID: 38775234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.
    Quintero E; Carrillo M; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Díez-Fuentes ML; Abraira V
    Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic yield and miss rate of EndoRings in an organized colorectal cancer screening program: the SMART (Study Methodology for ADR-Related Technology) trial.
    Hassan C; Senore C; Manes G; Fuccio L; Iacopini F; Ricciardiello L; Anderloni A; Frazzoni L; Ballanti R; de Nucci G; Colussi D; Redaelli D; Lorenzetti R; Devani M; Arena I; Grossi C; Andrei F; Balestrazzi E; Sharma P; Rex DK; Repici A
    Gastrointest Endosc; 2019 Mar; 89(3):583-590.e1. PubMed ID: 30365984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining adenoma detection rate benchmarks in average-risk male veterans.
    El-Halabi MM; Rex DK; Saito A; Eckert GJ; Kahi CJ
    Gastrointest Endosc; 2019 Jan; 89(1):137-143. PubMed ID: 30144416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of adenoma detection rate and adenoma per colonoscopy as a quality indicator of colonoscopy.
    Park SK; Kim HY; Lee CK; Cha JM; Eun CS; Han DS; Lee BI; Shin JE; Park DI
    Scand J Gastroenterol; 2016 Jul; 51(7):886-90. PubMed ID: 27001284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individualized colorectal cancer screening based on the clinical risk factors: beyond family history of colorectal cancer.
    Park CH; Kim NH; Park JH; Park DI; Sohn CI; Jung YS
    Gastrointest Endosc; 2018 Jul; 88(1):128-135. PubMed ID: 29510145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
    Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; Fasoli R; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex D; Hassan C; Zappa M;
    Gut; 2015 Sep; 64(9):1389-96. PubMed ID: 25227521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modifiable endoscopic factors that influence the adenoma detection rate in colorectal cancer screening colonoscopies.
    Jover R; Zapater P; Polanía E; Bujanda L; Lanas A; Hermo JA; Cubiella J; Ono A; González-Méndez Y; Peris A; Pellisé M; Seoane A; Herreros-de-Tejada A; Ponce M; Marín-Gabriel JC; Chaparro M; Cacho G; Fernández-Díez S; Arenas J; Sopeña F; de-Castro L; Vega-Villaamil P; Rodríguez-Soler M; Carballo F; Salas D; Morillas JD; Andreu M; Quintero E; Castells A;
    Gastrointest Endosc; 2013 Mar; 77(3):381-389.e1. PubMed ID: 23218945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal immunochemical test in colorectal cancer screening: Colonoscopy findings by different cut-off levels.
    Ribbing Wilén H; Blom J; Höijer J; Hultcrantz R
    J Gastroenterol Hepatol; 2019 Jan; 34(1):103-112. PubMed ID: 29968937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive Fecal Immunochemical Test Strongly Predicts Adenomas in Younger Adults With Fatty Liver and Metabolic Syndrome.
    Yeh JH; Lin CW; Wang WL; Lee CT; Chen JC; Hsu CC; Wang JY
    Clin Transl Gastroenterol; 2021 Feb; 12(2):e00305. PubMed ID: 33570858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenomas are detected more often in morning than in afternoon colonoscopy.
    Sanaka MR; Deepinder F; Thota PN; Lopez R; Burke CA
    Am J Gastroenterol; 2009 Jul; 104(7):1659-64; quiz 1665. PubMed ID: 19491841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pooled rates of adenoma detection by colonoscopy in asymptomatic average-risk individuals with positive fecal immunochemical test: a systematic review and meta-analysis.
    Mohan BP; Khan SR; Daugherty E; Chandan S; Ponnada S; Facciorusso A; Kassab LL; Asokkumar R; Adler DG
    Gastrointest Endosc; 2022 Aug; 96(2):208-222.e14. PubMed ID: 35413330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Faecal haemoglobin concentration influences risk prediction of interval cancers resulting from inadequate colonoscopy quality: analysis of the Taiwanese Nationwide Colorectal Cancer Screening Program.
    Chiu SY; Chuang SL; Chen SL; Yen AM; Fann JC; Chang DC; Lee YC; Wu MS; Chou CK; Hsu WF; Chiou ST; Chiu HM
    Gut; 2017 Feb; 66(2):293-300. PubMed ID: 26515543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenoma detection rate in high-risk patients differs from that in average-risk patients.
    Sanaka MR; Rai T; Navaneethan U; Gohel TD; Podugu A; Thota PN; Lopez R; Kiran RP; Burke CA
    Gastrointest Endosc; 2016 Jan; 83(1):172-8. PubMed ID: 26024584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenoma Detection Rate and Risk for Interval Postcolonoscopy Colorectal Cancer in Fecal Immunochemical Test-Based Screening : A Population-Based Cohort Study.
    Wisse PHA; Erler NS; de Boer SY; den Hartog B; Oudkerk Pool M; Terhaar Sive Droste JS; Verveer C; Meijer GA; Lansdorp-Vogelaar I; Kuipers EJ; Dekker E; Spaander MCW
    Ann Intern Med; 2022 Oct; 175(10):1366-1373. PubMed ID: 36162114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of two faecal immunochemical tests for the detection of advanced neoplasia at different positivity thresholds: a cross-sectional study of the Dutch national colorectal cancer screening programme.
    de Klerk CM; Wieten E; Lansdorp-Vogelaar I; Bossuyt PM; Spaander MC; Dekker E
    Lancet Gastroenterol Hepatol; 2019 Feb; 4(2):111-118. PubMed ID: 30497962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenoma detection rate metrics in colorectal cancer surveillance colonoscopy.
    Tjaden JM; Hause JA; Berger D; Duveneck SK; Jakate SM; Orkin BA; Hubbard EL; Melson JE
    Surg Endosc; 2018 Jul; 32(7):3108-3113. PubMed ID: 29340817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.